European Heart Journal

Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis

By Mihály Ruppert, Muthiah Vaduganathan, Brian Lee Claggett, Gerasimos S Filippatos

Trial in peopleInterventions

The paper

Semmelweis University; National and Kapodistrian University of Athens

European Heart Journal, 18 Aug 2026

doi.org/10.1093/eurheartj/ehag522 PubMed 42610431

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism4 Oct 2026
Blood proteins improve early cardiometabolic risk prediction
Journal of Clinical Medicine4 Oct 2026
Early physical therapy links to lower mortality in heart failure
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease